Carolina BioOncology (102)

Huntsville, North Carolina 28078

0 studies enrolling now · 2 studies all time

What they study most

Solid Tumor, Adult

Studies at this site

• First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors — Completed
• Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors — Completed